메뉴 건너뛰기




Volumn 24, Issue 3, 2009, Pages 295-301

Molecular pathways supporting the proliferation staging of malignant melanoma (Review)

Author keywords

Apoptosis; Cell differentiation; Cell proliferation; Malignant melanoma; Prognostic factor

Indexed keywords

B RAF KINASE; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27; PROTEIN P53; RAF PROTEIN;

EID: 70349477978     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000232     Document Type: Review
Times cited : (23)

References (87)
  • 2
    • 34548232762 scopus 로고    scopus 로고
    • Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I and EUROCARE-4 WorkingGroup: Recent cancer survival in Europe a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796, 2007.
    • Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I and EUROCARE-4 WorkingGroup: Recent cancer survival in Europe a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796, 2007.
  • 3
    • 31644449749 scopus 로고    scopus 로고
    • Histologic criteria for diagnosing primary cutaneous malignant melanoma
    • Smoller BR: Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol 19: 34-40, 2006.
    • (2006) Mod Pathol , vol.19 , pp. 34-40
    • Smoller, B.R.1
  • 4
    • 31644448492 scopus 로고    scopus 로고
    • Prognosticators of melanoma, the melanoma report, and the sentinel lymph node
    • Crowson N, Magro CM and Mihm MC: Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol 19: S71-S87, 2006.
    • (2006) Mod Pathol , vol.19
    • Crowson, N.1    Magro, C.M.2    Mihm, M.C.3
  • 5
    • 0036207667 scopus 로고    scopus 로고
    • Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions
    • Brochez L, Verhaeghe E, Grosshans E, Haneke E, Piérard G, Ruiter D and Naeyaert JM: Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 196: 459-466, 2002.
    • (2002) J Pathol , vol.196 , pp. 459-466
    • Brochez, L.1    Verhaeghe, E.2    Grosshans, E.3    Haneke, E.4    Piérard, G.5    Ruiter, D.6    Naeyaert, J.M.7
  • 9
    • 18344369398 scopus 로고    scopus 로고
    • Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement
    • Claessens N, Piérard GE, Piérard-Franchimont C, Arrese JE and Quatresooz P: Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res 15: 107-110, 2005.
    • (2005) Melanoma Res , vol.15 , pp. 107-110
    • Claessens, N.1    Piérard, G.E.2    Piérard-Franchimont, C.3    Arrese, J.E.4    Quatresooz, P.5
  • 11
    • 37349081263 scopus 로고    scopus 로고
    • Expression of immunohistochemical markers in primary and metastatic malignant melanoma: A comparative study in 70 patients using a tissue microarray technique
    • Plaza JA, Suster D and Perez-Montiel D: Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique. Appl Immunohistochem Mol Morphol 15: 421-425, 2007.
    • (2007) Appl Immunohistochem Mol Morphol , vol.15 , pp. 421-425
    • Plaza, J.A.1    Suster, D.2    Perez-Montiel, D.3
  • 13
    • 48849098320 scopus 로고    scopus 로고
    • Highlighting the immunohistochemical profile of melanocytomas
    • Quatresooz P, Piérard-Franchimont C and Piérard GE: Highlighting the immunohistochemical profile of melanocytomas. Oncol Rep 19: 1367-1372, 2008.
    • (2008) Oncol Rep , vol.19 , pp. 1367-1372
    • Quatresooz, P.1    Piérard-Franchimont, C.2    Piérard, G.E.3
  • 14
    • 84868949910 scopus 로고    scopus 로고
    • Molecular histology on the diagnostic cutting edge between malignant melanomas and melanocytomas
    • and the Mosan Study Group of Pigmented Neoplasms:, In press
    • Quatresooz P, Piérard-Franchimont C, Rorive A, Nizet JL, Piérard GE and the Mosan Study Group of Pigmented Neoplasms: Molecular histology on the diagnostic cutting edge between malignant melanomas and melanocytomas. Exp Rev Dermatol (In press).
    • Exp Rev Dermatol
    • Quatresooz, P.1    Piérard-Franchimont, C.2    Rorive, A.3    Nizet, J.L.4    Piérard, G.E.5
  • 16
    • 41049114747 scopus 로고    scopus 로고
    • How to make a melanoma: What do we know of the primary clonal events? Pigment Cell
    • Bennett C: How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21: 27-38, 2008.
    • (2008) Melanoma Res , vol.21 , pp. 27-38
    • Bennett, C.1
  • 18
    • 0025923920 scopus 로고
    • Ki-67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters
    • Soyer HP: Ki-67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters. J Cutan Pathol 18: 264-272, 1991.
    • (1991) J Cutan Pathol , vol.18 , pp. 264-272
    • Soyer, H.P.1
  • 19
    • 0028239571 scopus 로고
    • Karyometry of primary and metastatic malignant melanoma. A correlation with cell proliferation
    • Piérard-Franchimont C and Piérard GE: Karyometry of primary and metastatic malignant melanoma. A correlation with cell proliferation. Am J Dermatopathol 16: 247-252, 1994.
    • (1994) Am J Dermatopathol , vol.16 , pp. 247-252
    • Piérard-Franchimont, C.1    Piérard, G.E.2
  • 20
    • 0029775064 scopus 로고    scopus 로고
    • MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
    • Boni R, Doguoglu A, Burg G, Muller B and Dummer R: MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol 35: 416-418, 1996.
    • (1996) J Am Acad Dermatol , vol.35 , pp. 416-418
    • Boni, R.1    Doguoglu, A.2    Burg, G.3    Muller, B.4    Dummer, R.5
  • 22
    • 0029783806 scopus 로고    scopus 로고
    • Nuclear morphometry, immuno-histochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin
    • Talve LAI, Collan YUI and Ekfors TO: Nuclear morphometry, immuno-histochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. J Cutan Pathol 23: 335-343, 1996.
    • (1996) J Cutan Pathol , vol.23 , pp. 335-343
    • Talve, L.A.I.1    Collan, Y.U.I.2    Ekfors, T.O.3
  • 23
    • 0031891403 scopus 로고    scopus 로고
    • Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
    • Sparrow LE, English DR, Taran JM and Heenan PJ: Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 20: 12-16, 1998.
    • (1998) Am J Dermatopathol , vol.20 , pp. 12-16
    • Sparrow, L.E.1    English, D.R.2    Taran, J.M.3    Heenan, P.J.4
  • 25
    • 0034103810 scopus 로고    scopus 로고
    • Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
    • Straume O, Sviland L and Akslen LA: Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 6: 1845-1853, 2000.
    • (2000) Clin Cancer Res , vol.6 , pp. 1845-1853
    • Straume, O.1    Sviland, L.2    Akslen, L.A.3
  • 26
    • 0035677699 scopus 로고    scopus 로고
    • High proliferative activity may predict early metastasis of thin melanomas
    • Frahm SO, Schubert C, Parwaresch R and Rudolp P: High proliferative activity may predict early metastasis of thin melanomas. Hum Pathol 32: 1376-1381, 2001.
    • (2001) Hum Pathol , vol.32 , pp. 1376-1381
    • Frahm, S.O.1    Schubert, C.2    Parwaresch, R.3    Rudolp, P.4
  • 27
    • 0344301855 scopus 로고    scopus 로고
    • Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas
    • Piérard GE and Piérard-Franchimont C: Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 33: 1888-1892, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 1888-1892
    • Piérard, G.E.1    Piérard-Franchimont, C.2
  • 29
  • 30
    • 33845712739 scopus 로고    scopus 로고
    • Growth rate, early detection and prevention of melanoma. Melanoma epidemiology revisited and future challenges
    • Lipsker D: Growth rate, early detection and prevention of melanoma. Melanoma epidemiology revisited and future challenges. Arch Dermatol 142: 1638-1640, 2006.
    • (2006) Arch Dermatol , vol.142 , pp. 1638-1640
    • Lipsker, D.1
  • 32
    • 35248899866 scopus 로고    scopus 로고
    • DNA microarray analyses of melanoma gene expression: A decade in the mines
    • Hoek KS: DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res 20: 466-484, 2007.
    • (2007) Pigment Cell Res , vol.20 , pp. 466-484
    • Hoek, K.S.1
  • 35
    • 33947305783 scopus 로고    scopus 로고
    • Epigenetic events in malignant melanoma
    • Rothhammer T and Bosserhoff AK: Epigenetic events in malignant melanoma. Pigment Cell Res 20: 92-111, 2007.
    • (2007) Pigment Cell Res , vol.20 , pp. 92-111
    • Rothhammer, T.1    Bosserhoff, A.K.2
  • 36
    • 34047258036 scopus 로고    scopus 로고
    • Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays
    • Stark M and Hayward N: Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67: 2632-2642, 2007.
    • (2007) Cancer Res , vol.67 , pp. 2632-2642
    • Stark, M.1    Hayward, N.2
  • 37
    • 0035754080 scopus 로고    scopus 로고
    • To cycle or not to cycle: A critical decision in cancer
    • Malumbres M and Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231, 2001.
    • (2001) Nat Rev Cancer , vol.1 , pp. 222-231
    • Malumbres, M.1    Barbacid, M.2
  • 38
    • 0035092418 scopus 로고    scopus 로고
    • Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions
    • Georgieva J, Sinha P and Schadendorf D: Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions. J Clin Pathol 54: 229-235, 2001.
    • (2001) J Clin Pathol , vol.54 , pp. 229-235
    • Georgieva, J.1    Sinha, P.2    Schadendorf, D.3
  • 39
    • 0035668485 scopus 로고    scopus 로고
    • Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
    • Florenes VA, Maelandsmo GM, Faye R, Nesland JM and Holm R: Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol 195: 530-536, 2001.
    • (2001) J Pathol , vol.195 , pp. 530-536
    • Florenes, V.A.1    Maelandsmo, G.M.2    Faye, R.3    Nesland, J.M.4    Holm, R.5
  • 40
    • 0033822962 scopus 로고    scopus 로고
    • Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
    • Florenes VA, Faye RS, Maelandsmo GM, Nesland JM and Holm R: Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res 6: 3614-3620, 2000.
    • (2000) Clin Cancer Res , vol.6 , pp. 3614-3620
    • Florenes, V.A.1    Faye, R.S.2    Maelandsmo, G.M.3    Nesland, J.M.4    Holm, R.5
  • 42
    • 0030610586 scopus 로고    scopus 로고
    • NK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage
    • NK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. Int J Cancer 74: 255-259, 1997.
    • (1997) Int J Cancer , vol.74 , pp. 255-259
    • Talve, L.1    Sauroja, I.2    Collan, Y.3    Punnonen, K.4    Ekfors, T.5
  • 44
    • 16644400331 scopus 로고    scopus 로고
    • Altered expression of cell cycle regulators cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas
    • Bachmann IM, Straume O and Akslen LA: Altered expression of cell cycle regulators cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. Int J Oncol 25: 1559-1565, 2004.
    • (2004) Int J Oncol , vol.25 , pp. 1559-1565
    • Bachmann, I.M.1    Straume, O.2    Akslen, L.A.3
  • 48
    • 0030807729 scopus 로고    scopus 로고
    • Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas
    • Korabiowska M, Betke H, Kellner S, Stachura J and Schauer A: Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas. Anticancer Res 7: 3697-3700, 1997.
    • (1997) Anticancer Res , vol.7 , pp. 3697-3700
    • Korabiowska, M.1    Betke, H.2    Kellner, S.3    Stachura, J.4    Schauer, A.5
  • 50
    • 0032858974 scopus 로고    scopus 로고
    • Malignant melanoma arising from nevi, p53, p16, and bcl-2: Expression in benign versus malignant components
    • Rhadi JM: Malignant melanoma arising from nevi, p53, p16, and bcl-2: expression in benign versus malignant components. J Cutan Med Surg 3: 293-297, 1999.
    • (1999) J Cutan Med Surg , vol.3 , pp. 293-297
    • Rhadi, J.M.1
  • 51
    • 37549068850 scopus 로고    scopus 로고
    • Maspin and mutant p53 expression in malignant melanoma and carcinoma: Use of tissue microarray
    • Webber BA, Lawson D and Cohen C: Maspin and mutant p53 expression in malignant melanoma and carcinoma: use of tissue microarray. Appl Immunohistochem Mol Morphol 16: 19-23, 2008.
    • (2008) Appl Immunohistochem Mol Morphol , vol.16 , pp. 19-23
    • Webber, B.A.1    Lawson, D.2    Cohen, C.3
  • 52
    • 0038457811 scopus 로고    scopus 로고
    • Ki-67 and p53 expression in minimal deviation melanoma as compared with other nevomelanocytic lesions
    • Chorny JA, Barr RJ, Kyshtoobayeva A, Jakowatz J and Reed RJ: Ki-67 and p53 expression in minimal deviation melanoma as compared with other nevomelanocytic lesions. Mod Pathol 16: 525-529, 2003.
    • (2003) Mod Pathol , vol.16 , pp. 525-529
    • Chorny, J.A.1    Barr, R.J.2    Kyshtoobayeva, A.3    Jakowatz, J.4    Reed, R.J.5
  • 53
    • 0034934743 scopus 로고    scopus 로고
    • Immunohistochemical study of 49 cutaneous melanomas: P53, PCNA, Bcl-2 expression and multidrug resistance
    • Loggini B, Rinaldi I Pingitore R, Cristofani R, Catagna M and Barachini P: Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance. Tumori 87: 179-186, 2001.
    • (2001) Tumori , vol.87 , pp. 179-186
    • Loggini, B.1    Rinaldi, I.2    Pingitore, R.3    Cristofani, R.4    Catagna, M.5    Barachini, P.6
  • 56
    • 0037032817 scopus 로고    scopus 로고
    • Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
    • Johnson G and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2001.
    • (2001) Science , vol.298 , pp. 1911-1912
    • Johnson, G.1    Lapadat, R.2
  • 57
    • 34547913062 scopus 로고    scopus 로고
    • p38 MAPK inhibitors in dermatology
    • Ihn H: p38 MAPK inhibitors in dermatology. Expert Rev Dermatol 2: 403-407, 2007.
    • (2007) Expert Rev Dermatol , vol.2 , pp. 403-407
    • Ihn, H.1
  • 58
    • 16844376315 scopus 로고    scopus 로고
    • Oncogenic ras in tumour progression and metastasis
    • Giehl K: Oncogenic ras in tumour progression and metastasis. Biol Chem 386: 193-205, 2005.
    • (2005) Biol Chem , vol.386 , pp. 193-205
    • Giehl, K.1
  • 59
    • 1242340431 scopus 로고    scopus 로고
    • Campbell PM and Der CJ: Oncogenic ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14: 105-114, 2004.
    • Campbell PM and Der CJ: Oncogenic ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14: 105-114, 2004.
  • 60
    • 18444374405 scopus 로고    scopus 로고
    • Davies H, Gibnell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber GL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
    • Davies H, Gibnell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber GL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
  • 61
    • 27244457769 scopus 로고    scopus 로고
    • RAF, a strategic target for therapeutic development against cancer
    • Beeram M, Patnaik A and Rowinsky EK: RAF, a strategic target for therapeutic development against cancer. J Clin Oncol 23: 6771-6790, 2005.
    • (2005) J Clin Oncol , vol.23 , pp. 6771-6790
    • Beeram, M.1    Patnaik, A.2    Rowinsky, E.K.3
  • 62
    • 34248630805 scopus 로고    scopus 로고
    • Confirmation of a BRAF mutation-associated gene expression signature in melanoma
    • Johansson P, Pavey S and Hayward N: Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res 20: 216-221, 2007.
    • (2007) Pigment Cell Res , vol.20 , pp. 216-221
    • Johansson, P.1    Pavey, S.2    Hayward, N.3
  • 63
    • 0028152333 scopus 로고
    • MAP kinase kinase kinase, MAP kinase kinase and MAP kinase
    • Marshall CJ: MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4: 82-89, 1994.
    • (1994) Curr Opin Genet Dev , vol.4 , pp. 82-89
    • Marshall, C.J.1
  • 67
    • 0036654443 scopus 로고    scopus 로고
    • A genome-based strategy uncovers frequent BRAF mutations in melanoma
    • Pollock PM and Meltzer PS: A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2: 5-7, 2002.
    • (2002) Cancer Cell , vol.2 , pp. 5-7
    • Pollock, P.M.1    Meltzer, P.S.2
  • 69
    • 34547951896 scopus 로고    scopus 로고
    • Mechanism of UV-related carcinogenesis and its contribution to nevi/ melanoma. Expert Rev
    • Brozyna A, Zbytek B, Granese J, Carlson JA, Ross J and Slominski A: Mechanism of UV-related carcinogenesis and its contribution to nevi/ melanoma. Expert Rev Dermatol 2: 451-469, 2007.
    • (2007) Dermatol , vol.2 , pp. 451-469
    • Brozyna, A.1    Zbytek, B.2    Granese, J.3    Carlson, J.A.4    Ross, J.5    Slominski, A.6
  • 73
    • 2942607408 scopus 로고    scopus 로고
    • Constitutive activation of the ras-raf signalling pathway in metastatic melanoma is associated with poor prognosis
    • Houben R, Becker JC, Kappel A, Terheyden P, Bröcker EB, Goetz R and Rapp UR: Constitutive activation of the ras-raf signalling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog 3: 6, 2004.
    • (2004) J Carcinog , vol.3 , pp. 6
    • Houben, R.1    Becker, J.C.2    Kappel, A.3    Terheyden, P.4    Bröcker, E.B.5    Goetz, R.6    Rapp, U.R.7
  • 74
    • 27144527955 scopus 로고    scopus 로고
    • Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral and lentigo maligna subtypes
    • Lang J and MacKie RM: Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral and lentigo maligna subtypes. J Invest Dermatol 125: 575-579, 2005.
    • (2005) J Invest Dermatol , vol.125 , pp. 575-579
    • Lang, J.1    MacKie, R.M.2
  • 77
    • 33646705144 scopus 로고    scopus 로고
    • Melanoma genetics: A review of genetic factors and clinical phenotypes in familial melanoma
    • Pho L, Grossman D and Leachman SA: Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol 18: 173-179, 2006.
    • (2006) Curr Opin Oncol , vol.18 , pp. 173-179
    • Pho, L.1    Grossman, D.2    Leachman, S.A.3
  • 78
  • 82
    • 38449090512 scopus 로고    scopus 로고
    • Stem cells of the melanocyte lineage
    • Buac K and Pavan WJ: Stem cells of the melanocyte lineage. Cancer Biomark 3: 203-209, 2007.
    • (2007) Cancer Biomark , vol.3 , pp. 203-209
    • Buac, K.1    Pavan, W.J.2
  • 84
    • 41049111969 scopus 로고    scopus 로고
    • Cancer stem cells and human malignant melanoma
    • Schatton T and Franck MH: Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 21: 39-55, 2007.
    • (2007) Pigment Cell Melanoma Res , vol.21 , pp. 39-55
    • Schatton, T.1    Franck, M.H.2
  • 85
    • 58049201990 scopus 로고    scopus 로고
    • The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
    • Rappa G, Fodstad O and Lorico A: The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26: 2008-3017, 2008.
    • (2008) Stem Cells , vol.26 , pp. 2008-3017
    • Rappa, G.1    Fodstad, O.2    Lorico, A.3
  • 86
    • 0037372013 scopus 로고    scopus 로고
    • Apoptosis and melanoma: Molecular mechanisms
    • Hussein M, Haemel A and Wood ES: Apoptosis and melanoma: molecular mechanisms. J Pathol 199: 275-288, 2003.
    • (2003) J Pathol , vol.199 , pp. 275-288
    • Hussein, M.1    Haemel, A.2    Wood, E.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.